IO Biotech, Inc. (IOBT)
NASDAQ: IOBT · Real-Time Price · USD
1.180
-0.020 (-1.67%)
At close: Nov 4, 2024, 4:00 PM
1.190
+0.010 (0.85%)
After-hours: Nov 4, 2024, 4:36 PM EST
IO Biotech Employees
IO Biotech had 68 employees as of December 31, 2023. The number of employees increased by 11 or 19.30% compared to the previous year.
Employees
68
Change (1Y)
11
Growth (1Y)
19.30%
Revenue / Employee
n/a
Profits / Employee
-$1,294,176
Market Cap
77.74M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 68 | 11 | 19.30% |
Dec 31, 2022 | 57 | 25 | 78.13% |
Dec 31, 2021 | 32 | 21 | 190.91% |
Dec 31, 2020 | 11 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Metagenomi | 236 |
RAPT Therapeutics | 131 |
DBV Technologies | 105 |
ALX Oncology Holdings | 72 |
Aerovate Therapeutics | 51 |
Ovid Therapeutics | 40 |
Clearside Biomedical | 30 |
SELLAS Life Sciences Group | 16 |
IOBT News
- 4 weeks ago - IO Biotech Announces Two Poster Presentations at the Society for Immunotherapy of Cancer's (SITC) 39th Annual Meeting - GlobeNewsWire
- 7 weeks ago - IO Biotech Announces Positive Results from Phase 2 Trial of IO102-IO103 in the First-line Treatment of Advanced Head and Neck Cancer - GlobeNewsWire
- 2 months ago - IO Biotech Updates on Pivotal Phase 3 Trial of IO102-IO103 in Combination with KEYTRUDA® (pembrolizumab) as a First-Line Treatment for Patients with Advanced Melanoma - GlobeNewsWire
- 2 months ago - IO Biotech Announces Participation in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - IO Biotech Reports Second Quarter 2024 Financial Results and Provides Business Highlights - GlobeNewsWire
- 3 months ago - IO Biotech Announces New Head and Neck Cohort Data Accepted for Presentation at ESMO Congress 2024 - GlobeNewsWire
- 5 months ago - IO Biotech to Present at Jefferies Global Healthcare Conference - GlobeNewsWire
- 6 months ago - IO Biotech Reports First Quarter 2024 Financial Results and Provides Business Highlights - GlobeNewsWire